LFSC vs. PSCH
Compare and contrast key facts about F/m Emerald Life Sciences Innovation ETF (LFSC) and Invesco S&P SmallCap Health Care ETF (PSCH).
LFSC and PSCH are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. LFSC is an actively managed fund by F/m Investments. It was launched on Oct 30, 2024. PSCH is a passively managed fund by Invesco that tracks the performance of the S&P SmallCap 600 Health Care Index. It was launched on Apr 7, 2010.
Performance
LFSC vs. PSCH - Performance Comparison
Loading graphics...
LFSC vs. PSCH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
LFSC F/m Emerald Life Sciences Innovation ETF | -4.45% | 56.54% | -6.02% |
PSCH Invesco S&P SmallCap Health Care ETF | -6.37% | -0.49% | 2.19% |
Returns By Period
In the year-to-date period, LFSC achieves a -4.45% return, which is significantly higher than PSCH's -6.37% return.
LFSC
- 1D
- 6.16%
- 1M
- -3.82%
- YTD
- -4.45%
- 6M
- 17.66%
- 1Y
- 55.83%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
PSCH
- 1D
- 0.25%
- 1M
- -4.93%
- YTD
- -6.37%
- 6M
- -1.85%
- 1Y
- -2.33%
- 3Y*
- -1.76%
- 5Y*
- -7.33%
- 10Y*
- 6.54%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
LFSC vs. PSCH - Expense Ratio Comparison
LFSC has a 0.54% expense ratio, which is higher than PSCH's 0.29% expense ratio.
Return for Risk
LFSC vs. PSCH — Risk / Return Rank
LFSC
PSCH
LFSC vs. PSCH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for F/m Emerald Life Sciences Innovation ETF (LFSC) and Invesco S&P SmallCap Health Care ETF (PSCH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| LFSC | PSCH | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.93 | -0.10 | +2.03 |
Sortino ratioReturn per unit of downside risk | 2.65 | 0.02 | +2.63 |
Omega ratioGain probability vs. loss probability | 1.33 | 1.00 | +0.33 |
Calmar ratioReturn relative to maximum drawdown | 3.20 | -0.30 | +3.50 |
Martin ratioReturn relative to average drawdown | 8.96 | -0.75 | +9.71 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| LFSC | PSCH | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.93 | -0.10 | +2.03 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | -0.32 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.28 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.94 | 0.49 | +0.45 |
Correlation
The correlation between LFSC and PSCH is 0.74, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
LFSC vs. PSCH - Dividend Comparison
LFSC has not paid dividends to shareholders, while PSCH's dividend yield for the trailing twelve months is around 0.01%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
LFSC F/m Emerald Life Sciences Innovation ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
PSCH Invesco S&P SmallCap Health Care ETF | 0.01% | 0.04% | 0.27% | 0.01% | 2.27% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.03% |
Drawdowns
LFSC vs. PSCH - Drawdown Comparison
The maximum LFSC drawdown since its inception was -29.74%, smaller than the maximum PSCH drawdown of -46.32%. Use the drawdown chart below to compare losses from any high point for LFSC and PSCH.
Loading graphics...
Drawdown Indicators
| LFSC | PSCH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -29.74% | -46.32% | +16.58% |
Max Drawdown (1Y)Largest decline over 1 year | -16.25% | -15.36% | -0.89% |
Max Drawdown (5Y)Largest decline over 5 years | — | -46.32% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -46.32% | — |
Current DrawdownCurrent decline from peak | -11.08% | -36.16% | +25.08% |
Average DrawdownAverage peak-to-trough decline | -8.25% | -13.26% | +5.01% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.80% | 6.25% | -0.45% |
Volatility
LFSC vs. PSCH - Volatility Comparison
F/m Emerald Life Sciences Innovation ETF (LFSC) has a higher volatility of 10.35% compared to Invesco S&P SmallCap Health Care ETF (PSCH) at 8.55%. This indicates that LFSC's price experiences larger fluctuations and is considered to be riskier than PSCH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| LFSC | PSCH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.35% | 8.55% | +1.80% |
Volatility (6M)Calculated over the trailing 6-month period | 19.97% | 14.88% | +5.09% |
Volatility (1Y)Calculated over the trailing 1-year period | 29.24% | 23.32% | +5.92% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 29.31% | 22.91% | +6.40% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 29.31% | 23.64% | +5.67% |